Angela Cramer
- Cancer Research top 10%
- Breast Cancer Treatment Studies 3
- Oncology top 10%
- HER2/EGFR in Cancer Research 6
- Cancer Treatment and Pharmacology 2
- Cancer Cells and Metastasis 2
- Peptidase Inhibition and Analysis 2
-
- Estrogen and related hormone effects 4
-
- Advanced Breast Cancer Therapies 2
-
- Yeasts and Rust Fungi Studies 2
- Co-authors
- Nigel BundredW.F. KnoxG.P. BolandNicola BarnesFiona KnoxJulie MorrisMiles HoweKathryn Williams
- Partner nations
- United KingdomUnited StatesNetherlands
In The Last Decade
Angela Cramer
18 papers receiving 500 citations
Peers
Comparison fields: 5 of 55
- Cancer Research 176
- Oncology 287
- Pathology and Forensic Medicine 93
- Genetics 133
- Immunology and Allergy 28
Countries citing papers authored by Angela Cramer
This map shows the geographic impact of Angela Cramer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Angela Cramer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Angela Cramer more than expected).
Fields of papers citing papers by Angela Cramer
This network shows the impact of papers produced by Angela Cramer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Angela Cramer. The network helps show where Angela Cramer may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Angela Cramer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 0 | |
| 3 | 2021 | 22 | |
| 4 | 2018 | 17 | |
| 5 | Effects of perioperative lapatinib and trastuzumab, alone and in combination, in early HER2+breast cancer - the UK EPHOS-B trial (CRUK/08/002) | 2016 | 4 |
| 6 | 2016 | 2 | |
| 7 | 2015 | 86 | |
| 8 | 2012 | 20 | |
| 9 | 2011 | 46 | |
| 10 | 2010 | 33 | |
| 11 | 2010 | 2 | |
| 12 | 2010 | 1 | |
| 13 | 2009 | 67 | |
| 14 | 2009 | 1 | |
| 15 | 2006 | 58 | |
| 16 | 2006 | 4 | |
| 17 | 2005 | 117 | |
| 18 | 2003 | 22 | |
| 19 | Ulcerated breast cancer. Patients and outcome. | 1983 | 3 |
About Angela Cramer
Angela Cramer is a scholar working on Oncology, Immunology and Allergy, Cancer Research, Genetics and Obstetrics and Gynecology, having authored 19 papers that have together received 506 indexed citations. Recurring topics across this work include HER2/EGFR in Cancer Research (6 papers), Estrogen and related hormone effects (4 papers), Breast Cancer Treatment Studies (3 papers), Advanced Breast Cancer Therapies (2 papers), Yeasts and Rust Fungi Studies (2 papers), Cancer Treatment and Pharmacology (2 papers), Cancer Cells and Metastasis (2 papers) and Peptidase Inhibition and Analysis (2 papers). The work is most often cited by research in Cancer Research (176 citations), Oncology (287 citations), Pathology and Forensic Medicine (93 citations), Genetics (133 citations) and Immunology and Allergy (28 citations). Angela Cramer has collaborated with scholars based in United Kingdom, United States and Netherlands. Frequent co-authors include Nigel Bundred, W.F. Knox, G.P. Boland, Nicola Barnes, Fiona Knox, Julie Morris, Miles Howe, Kathryn Williams, D. Gareth Evans and Fiona Lalloo. Their work appears in journals such as Clinical Cancer Research, Cancer Research, Cancer, British Journal of Cancer and Phytopathology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.